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Abstract  
 The near-infrared (NIR) sensitive Au-Au2S nanoparticles (NPs) have shown many advantages as 
potential drug delivery systems. To further investigate biological safety of Au-Au2S NPs, 
cytotoxicity was estimated by calcein AM/EthD-1 fluorescence staining and the lactate 
dehydrogenase (LDH) release. The effects of NPs on apoptosis of CHL cells were determined by 
flow cytometry with Annexin V-FITC/PI double staining. It is evident that the Au-Au2S NPs are 
non-cytotoxic below IC50 dosage.  
Introduction 
 Au-Au2S nanoparticles (NPs) are composites of amorphous Au2S and Au crystallites having 
distinctive near-IR sensitive properties that depend on their size and composition, being tailored by 
varying concentration ratio of precursors [1]. Since NIR light (650-1000 nm) with deep penetration 
in living tissues, the unique optical property of Au-Au2S NPs might open up their fascinating 
applications in biomedical imaging, photoablation and photodynamic therapy. In our early previous 
studies [2], cisplatin, one of the most widely used and effective cytotoxic agents in treatment of 
malignancy of lung, head, neck, testes, and ovary [3], was loaded onto Au–Au2S NPs through an 
11-mercaptoundecanoic acid (MUA) layer to develop a targeted drug delivery system. Moreover, 
irradiation of pulsed NIR laser light (Nd:YAG pulse laser at λ = 1064 nm) could effectively induce 
the release of cisplatin from the NPs [2]. However, a crucial issue, which needs to be addressed 
before NIR sensitive Au-Au2S NPs are commercially available for drug carriers, is toxicity of these 
materials. The present study was thus undertaken in order to further investigate the cytotoxicity and 
cell apoptosis inducing by NIR sensitive cisplatin-loaded Au-Au2S NPs for potential cancer therapy. 
Materials and methods 
 Au-Au2S NPs and cisplatin-loaded Au-Au2S NPs were prepared as previously described [2]. The 
reaction was monitored by using a UV-visible spectrophotometer (DUTM800, Beckman coulter) at a 
range of 400 - 1100 nm. The morphological examination of the as-synthesized NPs was performed by 
transmission electron microscope (TEM, JEM 2100) at 120 kV. Cisplatin was loaded onto Au-Au2S 
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NPs via a MUA layer. 
 For cell culture, NPs were filtered by 0.22 µm membranes to be sterilized before use. Cells were 
cultured in DMEM with 10% fetal bovine serum (FBS) and 1% penicillin and streptomycin at 37
o
C 
and 5% CO2. For cell viability assay, Hela cells at a density of 10
5
 cells/well were respectively 
exposed to cisplatin (100 µg/mL) and cisplatin-loaded Au-Au2S NPs (100 µg/mL) for 24 h, and then 
transferred to a glass microscope slide, and incubated with LIVE/DEAD Viability/Cytotoxicity Kit 
(Sigma) following the protocol. A confocal fluorescence microscope (Olympus FluoView FV300, 
Japan) supplied with a filter set (EX 450-490 nm, EM 520 nm) was used in order to carry out the 
observations. For LDH assay, CHL cells at a density of 5×10
4
 cells/well were respectively 
co-cultured with Au-Au2S NPs (500 µg/mL) or cisplatin-loaded Au-Au2S NPs (200 µg/mL) for 24 
h, the cell culture medium was then collected for LDH determination, utilizing a commercial 
available kit following the protocol. The data is presented as mean and standard deviation (SD) 
calculated over three data points at least. Statistical significance of differences was evaluated by a two 
tailed unpaired Student t-test. A value of P < 0.05 was considered significant. 
 Cell apoptosis induced by NPs was assayed by annexin V-FITC apoptosis detection kit. The kit 
comprised of two individual stains: the binding of annexin V-FITC to phosphatidylserine present in 
the outer membrane of cells that are starting the apoptotic process and propidium iodide (PI) to assess 
cell viability. The cells at a density of 5 x 10
4
/well were co-cultured with NPs for 24 h, and 
subsequently mixed with binding buffer (HEPES buffered PBS supplemented with 2.5 mM CaCl2), 2 
µL of annexin V-FITC, and 5 µL of PI at 25
o
C for 15 min in the dark, following the protocol. 
Fluorescene-activated cell sorting (FACS) was finally used to determine the apoptotic or necrotic 
cells. Viable, apoptotic, and necrotic cells are designed as annexin-/PI-, annexin+/PI-, and 
annexin+/PI+, respectively. 
Results and discussion 
 Au–Au2S NPs were obtained by reduction of 
tetrachloroauric acid (HAuCl4) using sodium sulfide (Na2S) 
[2]. As illustrated in Fig. 1, the polygonal particles with ~ 40 
nm in size exhibited two absorption bands: band I at 527 nm 
was assigned to the surface plasmon resonance of the Au NPs, 
whereas band II at 766 nm (NIR region) was attributed to 
multiply-twinned Au-rich particles containing S [1]. Moreover, 
we also loaded 30 mg cisplatin onto per mg Au–Au2S NPs via a 
MUA layer [2]. 
 To detect the cytotoxicity, calcein AM/EthD-1 
fluorescence staining assay was carried out. Live cells are 
distinguished by the presence of ubiquitous intracellular 
esterase activity, which converts the virtually nonfluorescent 
cell-permeant calcein AM to the intensely fluorescent calcein, 
producing an intense uniform green fluorescence in live cells 
[4]. Dead cells usually are characterized by EthD-1 could enter dead cells, due to the damaged 
membranes, thereby producing a bright red fluorescence in dead cells; whereas EthD-1 is excluded 
by the intact plasma membrane of live cells [4]. As shown in Fig.2, it is apparent that exposure to 100 
µg/mL cisplatin caused significant cell death compared to the control (unexposed); whereas viable 
Fig.1 TEM image and UV–vis 
spectrum of Au–Au2S NPs. 
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cells was observed after co-culture with 100 µg/mL cisplatin loaded Au-Au2S NPs, though with an 
altered shape. 
 According to the MTT assay [5], 500 µg/mL of 
Au-Au2S NPs and 200 µg/mL of cisplatin loaded 
Au–Au2S NPs inhibited cell growth by 50% (IC50), 
respectively. For further evaluating the cytotoxicity at the 
dosage of IC50, LDH release assay was carried out. As 
shown in Fig. 3, though the LDH level of the cell culture 
media respectively increased 4.95% and 10.68% for 
Au-Au2S NPs or cisplatin-loaded Au-Au2S NPs groups, 
there was no significant difference comparing with the 
control group. It is thus suggested that at IC50 level, those 
NIR sensitive nanoparticles did not cause cell death. 
 To further understand whether the those NIR sensitive 
nanoparticles might cause cell damage through apoptosis in 
cells, the annexin V- FITC/PI apoptosis assay was 
Fig.2 The CLSM images of Hela cells, which were exposed to (A) control; (B) 100 µg/mL 
cisplatin; (C) 100 µg/mL cisplatin loaded Au-Au2S NP for 24 h, respectively.  
Fig.4 FCAS of apoptosis/necrosis in CHL cells after treated with (A) medium only, (B) 
Au-Au2S NPs, and (C) cisplatin-loaded Au-Au2S NPs for 24 h. 
Fig.3 LDH leakage of CHL cells after 
exposed to Au-Au2S NPs (NPs); and 
cisplatin-loaded Au-Au2S NPs 
(Pt-NPs) for 24 h. 
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employed, in which apoptotic cells were probed by green annexin V- FITC dye and the necrotic cells 
were stained by red dye propidium iodide. Compared to the control group (Fig.4A), the population 
of health cells in the Au-Au2S NPs and cisplatin-loaded Au-Au2S NPs groups, decreased by 21.3% 
(Fig.4B III) and 22.4% (Fig.4C III), respectively. Meanwhile, early apoptosis cells showed an 
increase of 14.7% (Fig.4B I), 17.6% (Fig.4C I), and late necrotic cells increased 5.86% (Fig.4B II), 
4.42% (Fig.4C II), respectively. Nevertheless, 500 µg/mL Au-Au2S NPs and 200 µg/mL 
cisplatin-loaded Au-Au2S NPs could only induce slight necrosis (Fig.4B, C IV). Combination the 
earlier data of MTT assay, two-stage cell transformation assay in vitro, hemolysis assay, 
pathological examine [5-7], it is thus suggested that those NIR sensitive nanoparticles are non-toxic 
below the maximum recommended dosage. 
Summary 
 The calcein AM/EthD-1 fluorescence staining assay, LDH release assay, and annexin V- 
FITC/PI apoptosis assay revealed that below IC50 dosage, Au-Au2S NPs and cisplatin-loaded 
Au-Au2S NPs could only induce slight necrosis, but not cell death. Considering the earlier reported 
data [1, 5-7], it is possible to employ NIR sensitive cisplatin-loaded Au-Au2S NPs for cancer therapy 
in the future. 
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